ProSciento, Inc.

Happy #StPatricksDay from ProSciento! May your day be filled with good health, a little magic, and maybe a shamrock shake or two! We’re feeling extra green today! Pinch us, because we’re lucky to work with an incredible team and amazing partners who are committed to scientific excellence and advancing metabolic research. #MissionCentered #MetabolicContinuum

Women in science, research, and healthcare are shaping the future of metabolic disease treatment options. This International Women’s Day, we celebrate the remarkable women at ProSciento and across the industry who are pushing boundaries and making a difference in patient lives. #IWD2025 #WomenInScience #AccelerateAction #ClinicalResearch

At ProSciento, we care deeply about fostering a culture of teamwork, well-being, and professional growth. Our commitment to scientific and operational excellence is driven by a mindset of always looking for a better way. Today, on #EmployeeAppreciationDay we recognize our exceptional team members who embody this spirit every day. Thank you for making a meaningful impact in science, for patients, and in our community. #MissionCentered #ClinicalResearch

ProSciento is proud to sponsor #ObesityCareWeek and support its mission to advance accessible, compassionate, and evidence-based obesity care. As a leader in obesity clinical research, we recognize that obesity is a complex disease requiring comprehensive solutions—free from stigma and bias. This year’s theme, “Commit to Care,” resonates deeply with our work, driving innovation in clinical trials that improve patient access and outcomes. Join us in advocating for better obesity care! #CommitToCare #FindingBetterTreatments #ScienceDriven #PatientFocused #MissionCentered

Obesity is a complex, chronic disease that contributes to serious health conditions like diabetes, heart disease, and MASLD/MASH. On this #WorldObesityDay, we recognize the global impact of obesity and the urgent need for continued research and innovation. The World Obesity Federation projects that by 2035, 1 in 4 people worldwide will be living with obesity. At ProSciento, we are proud to collaborate with pharmaceutical and biotechnology companies, advocacy groups, and academic researchers who are dedicated to advancing obesity research, treatments, and therapeutics. Learn more about our expertise in obesity clinical research: https://lnkd.in/guqG3dA4 #PatientFocused #ObesityResearch #HealthForAll

March is #NationalNutritionMonth, a time to spotlight the vital role of nutrition in metabolic clinical trials. We extend our gratitude to our dedicated team members, researchers, healthcare professionals, and educators for their continued efforts in improving global nutrition and metabolic health. At ProSciento, we recognize the intricate connection between nutrition, metabolic diseases, and overall well-being. We ensure clinical study participants receive consistent, balanced, and well-defined diets to support the accurate interpretation of clinical interventions. Together, we are advancing metabolic health through the power of nutrition. #NutritionResearch #MetabolicContinuum

Stigma surrounding diabetes directly impacts quality of care and life. Nearly 7 in 10 people with diabetes report experiencing bias, and 4 in 10 have skipped medical appointments because of it. At ProSciento, we are committed to challenging these harmful stereotypes by prioritizing patient experience and fostering a supportive environment. Through research, education, and advocacy, we can break down barriers and ensure everyone receives the care they deserve. Together, we can create a future free from stigma. #DiabetesAwareness #DiabetesResearch #PatientFocused

Happy Valentine’s Day from the team at ProSciento! Love is at the heart of everything we do. Our passion for advancing research in obesity, diabetes, and steatotic liver disease is driven by a commitment to find better treatments—so that everyone can spend more time with the ones they love. Today, we celebrate the dedication of our teams, the resilience of patients, and the study participants and partnerships that make progress possible. #ValentinesDay #MetabolicContinuum #PatientFocused

A co-authored poster by ProSciento and Nordic Bioscience was presented at the EASL | The Home of Hepatology by Diana Julie Leeming, mMBA, MSc, PhD, Senior Director, Hepatic & Pulmonary Research at Nordic Bioscience. The poster explores non-invasive biomarkers for hepatic fibrosis in patients at risk of metabolic dysfunction-associated steatohepatitis (MASH). MASH-related fibrosis results from excessive collagen deposition, increasing liver stiffness. Our research investigates how PRO-C3, PRO-C4, and PRO-C6 biomarkers—which assess fibroblast activation and endothelial damage—correlate with liver stiffness in patients at risk due to obesity and type 2 diabetes. View abstract: https://lnkd.in/gJMHgNwb #NordicBioscience #SLDSummit #SLD #MASH #LiverHealth #Obesity #Type2Diabetes #T2D #ClinicalResearch #Biomarkers #MetabolicContinuum #FindingBetterTreatments #ScienceDriven #PatientFocused #MissionCentered 

Happy Lunar New Year! ProSciento extends our warmest wishes for health, happiness, and success to our valued clients, partners, and community as we welcome the Year of the Snake. May this year bring growth, new opportunities, and shared prosperity for all. #YearOfTheSnake #LunarNewYear #LunarNewYear2025 #MetabolicContinuum #FindingBetterTreatments #ScienceDriven #PatientFocused #MissionCentered